http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106822859-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a06a1b6b86b0755ca87d0955de40c67
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99528aee8455afde733088a0faf7bb33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ec048383da07430fd99180b9362e29
publicationDate 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106822859-A
titleOfInvention A kind of enalapril maleate tablet and preparation method thereof
abstract The invention discloses an enalapril maleate tablet and a preparation method thereof, belonging to the technical field of pharmaceutical preparations. The enalapril maleate tablet is made of the following components in parts by weight: enalapril maleate 0.25-1.02 parts of lactose, 7-9 parts of lactose, 0.5-1.5 parts of corn starch, 0.1-0.2 parts of povidone, and 0.1-0.3 parts of glyceryl distearate. The composition of auxiliary materials selected by the present invention and the synergistic effect of the preparation process significantly reduce the degradation rate of enalapril maleate, greatly improve the stability of enalapril maleate tablet products, and solve the problem of existing products. Existing quality problems are conducive to ensuring the safety, effectiveness and long-term storage of clinical medication.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109350733-A
priorityDate 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0119348-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451646703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534469
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31351
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420663450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388961
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30426

Total number of triples: 49.